These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


618 related items for PubMed ID: 19647382

  • 1. Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women.
    Utian W, Yu H, Bobula J, Mirkin S, Olivier S, Pickar JH.
    Maturitas; 2009 Aug 20; 63(4):329-35. PubMed ID: 19647382
    [Abstract] [Full Text] [Related]

  • 2. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
    Bachmann G, Bobula J, Mirkin S.
    Climacteric; 2010 Apr 20; 13(2):132-40. PubMed ID: 19863455
    [Abstract] [Full Text] [Related]

  • 3. Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial.
    Pinkerton JV, Pan K, Abraham L, Racketa J, Ryan KA, Chines AA, Mirkin S.
    Menopause; 2014 Mar 20; 21(3):252-9. PubMed ID: 23942245
    [Abstract] [Full Text] [Related]

  • 4. Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women.
    Yu H, Racketa J, Chines AA, Mirkin S.
    Climacteric; 2013 Apr 20; 16(2):252-7. PubMed ID: 23035721
    [Abstract] [Full Text] [Related]

  • 5. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
    Pinkerton JV, Utian WH, Constantine GD, Olivier S, Pickar JH.
    Menopause; 2009 Apr 20; 16(6):1116-24. PubMed ID: 19546826
    [Abstract] [Full Text] [Related]

  • 6. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
    Pinkerton JV, Pickar JH, Racketa J, Mirkin S.
    Climacteric; 2012 Oct 20; 15(5):411-8. PubMed ID: 22853444
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens.
    Bushmakin AG, Abraham L, Pinkerton JV, Cappelleri JC, Mirkin S.
    Menopause; 2014 Aug 20; 21(8):815-22. PubMed ID: 24378765
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the direct and indirect effects of bazedoxifene/conjugated estrogens on sleep disturbance using mediation modeling.
    Pinkerton JV, Bushmakin AG, Racketa J, Cappelleri JC, Chines AA, Mirkin S.
    Menopause; 2014 Mar 20; 21(3):243-51. PubMed ID: 23899830
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.
    Pinkerton JV, Abraham L, Bushmakin AG, Cappelleri JC, Racketa J, Shi H, Chines AA, Mirkin S.
    J Womens Health (Larchmt); 2014 Jan 20; 23(1):18-28. PubMed ID: 24206058
    [Abstract] [Full Text] [Related]

  • 10. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar 20; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 11. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S, Komm BS.
    Maturitas; 2013 Nov 20; 76(3):213-20. PubMed ID: 23849704
    [Abstract] [Full Text] [Related]

  • 12. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
    Abraham L, Pinkerton JV, Messig M, Ryan KA, Komm BS, Mirkin S.
    Maturitas; 2014 Jul 20; 78(3):212-8. PubMed ID: 24837362
    [Abstract] [Full Text] [Related]

  • 13. Using bazedoxifene plus conjugated estrogens for treating postmenopausal women: a comprehensive review.
    Taylor HS, Ohleth K.
    Menopause; 2012 Apr 20; 19(4):479-85. PubMed ID: 22278343
    [Abstract] [Full Text] [Related]

  • 14. Changes in bone mineral density are correlated with bone markers and reductions in hot flush severity in postmenopausal women treated with bazedoxifene/conjugated estrogens.
    Gallagher JC, Shi H, Mirkin S, Chines AA.
    Menopause; 2013 Nov 20; 20(11):1126-32. PubMed ID: 23632659
    [Abstract] [Full Text] [Related]

  • 15. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH, Mirkin S.
    Menopause Int; 2010 Sep 20; 16(3):121-8. PubMed ID: 20956688
    [Abstract] [Full Text] [Related]

  • 16. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.
    Pinkerton JV, Stovall DW.
    Expert Opin Investig Drugs; 2010 Dec 20; 19(12):1613-21. PubMed ID: 21073353
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.
    Palacios S, Arias L, Lavenberg J, Pan K, Mirkin S, Komm BS.
    Climacteric; 2016 Jun 20; 19(3):261-7. PubMed ID: 26940720
    [Abstract] [Full Text] [Related]

  • 18. Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials.
    Archer DF, Freeman EW, Komm BS, Ryan KA, Yu CR, Mirkin S, Pinkerton JV.
    J Womens Health (Larchmt); 2016 Nov 20; 25(11):1102-1111. PubMed ID: 27676118
    [Abstract] [Full Text] [Related]

  • 19. Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women.
    Abraham L, Bushmakin AG, Dragon E, Komm BS, Pinkerton JV.
    Maturitas; 2016 Dec 20; 94():173-179. PubMed ID: 27823739
    [Abstract] [Full Text] [Related]

  • 20. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
    Mirkin S, Komm BS, Pan K, Chines AA.
    Climacteric; 2013 Jun 20; 16(3):338-46. PubMed ID: 23038989
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.